6.61 USD
↗ 2.19 (49.55%)AT CLOSE (11:59 AM EDT)
Zentalis Pharmaceuticals, Inc. Common Stock
ZNTLNASDAQ • USD
6.61
↘ 0.14 (2.04%)
POST MARKET (AS OF 04:49 PM EDT)
Post Market
AS OF 04:49 PM EDT
6.61
↘ 0.14 (2.04%)
Market: OPEN
Open?$4.52
High?$6.95
Low?$4.52
Prev. Close?$4.42
Volume?46.1M
Avg. Volume?1.1M
VWAP?$6.12
Rel. Volume?41.78x
Bid / Ask
Bid?$5.69 × 100
Ask?$7.48 × 100
Spread?$1.79
Midpoint?$6.59
Valuation & Ratios
Market Cap?313.5M
Shares Out?70.9M
Float?45.7M
Float %?63.4%
P/E Ratio?N/A
P/B Ratio?1.45
EPS?-$1.93
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?6.93Strong
Quick Ratio?6.93Strong
Cash Ratio?0.98Adequate
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score100/100
P/E?N/A▾
P/B?1.45CHEAP▾
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-1.9CHEAP▾
EV/Sales?N/A▾
Returns & Efficiency
ROE?-63.4%WEAK▾
ROA?-47.4%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$277.5M
Related Companies
Loading...
News
Profile
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
Employees
106
Market Cap
313.5M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2020-04-03
Address
10275 SCIENCE CENTER DRIVE
SAN DIEGO, CA 92121
Phone: (858) 263-4333
SAN DIEGO, CA 92121
Phone: (858) 263-4333